FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Tegretol XR (carbamazepine) by Novartis Pharmaceuticals Corporation, typically resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Trigeminal Neuralgia

Drugs mentioned

• TEGRETOL XR (carbamazepine)

Snippet

SUPPL AP for TEGRETOL XR (CARBAMAZEPINE)